225
Views
3
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Hodgkin disease (1973–2002): long-term survival and cure fractions

&
Pages 1278-1285 | Received 05 May 2014, Accepted 22 Jul 2014, Published online: 09 Oct 2014

References

  • Cancer Research UK. Hodgkin lymphoma Key Facts. 2013. Available from: www.cancerresearchuk.org/cancer-info/cancerstats/keyfacts/hodgkin-lymphoma/hodgkin-lymphoma
  • Bessell EM, Bouliotis G, Armstrong, et al. Long-term survival after treatment for Hodgkin's disease: improved survival with successive 10-year cohorts (1973–2002). Br J Cancer 2012;107:531–536.
  • Forsyth PD, Bessell EM, Moloney AJ, et al. Hodgkin's disease in patients older than 70 years of age: a registry-based analysis. Eur J Cancer 1997;33:1638–1642.
  • Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med 2006;260:103–117.
  • Swerdlow AJ, Douglas AJ, Vaughan Hudson G, et al. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation Br Med J 1992;304:1137–1143.
  • Thompson CA, Cerhan JR. Fruit and vegetable intake and survival from non-Hodgkin lymphoma: does an apple a day keep the doctor away? Leuk Lymphoma 2010;51:963–964.
  • Perme MP, Stare J, Esteve J. On estimation in relative survival. Biometrics 2012;68:113–120.
  • Rutherford MJ, Dickman PW, Lambert PC. Comparison of methods for calculating relative survival in population-based studies. Cancer Epidemiol 2012;36:16–21.
  • Cutler SJ, Ederer F, Griswold MH, et al. Survival of breast-cancer patients in Connecticut, 1935-54. J Natl Cancer Inst 1959;23: 1137–1156.
  • Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note no.10 end results evaluation section. Bethesda MD: National Cancer Institute; 1959.
  • Hakulinen T, Tenkanen L. Regression-analysis of relative survival rates. Applied statistics. J R Stat Soc C 1987;36:309–317.
  • Brenner H, Gefeller O. Deriving more up-to-date estimates of long-term patient survival. J Clin Epidemiol 1997;50:211–216.
  • Lenner P. The excess mortality-rate - a useful concept in cancer-epidemiology. Acta Oncol 1990;29:573–576.
  • Dickman PW, Sloggett A, Hills M, et al. Regression models for relative survival. Stat Med 2004;23:51–64.
  • Royston P, Lambert PC. Flexible parametric survival analysis using Stata: beyond the Cox model. College Station, TX: Stata Press; 2011.
  • Farewell VT. The use of mixture-models for the analysis of survival-data with long-term survivors. Biometrics 1982;38:1041–1046.
  • Maller RA, Zhou X. Survival analysis with long-term survivors. Chichester: Wiley; 1996.
  • Tsodikov A, Loeffler M, Yakovlev A. A cure model with time-changing risk factor: an application to the analysis of secondary leukaemia. A report from the international database on Hodgkin's disease. Stat Med 1998;17:27–40.
  • Sposto R. Cure model analysis in cancer: an application to data from the Children's Cancer Group. Stat Med 2002;21:293–312.
  • Yin GS, Ibrahim JG. Cure rate models: a unified approach. Can J Stat Rev Can Stat 2005;33:559–570.
  • De Angelis R, Capocaccia R, Hakulinen T, et al. Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med 1999;18:441–454.
  • Lambert PC, Thompson JR, Weston CL, et al. Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics 2007;8:576–594.
  • Hakulinen T. On long-term relative survival rates. J Chron Dis 1977;30:431–43.
  • StataCorp. Stata statistical software: release 12. College Station, TX: StataCorp LP; 2011.
  • Monnereau A, Troussard X, Belot A, et al. Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France. Int J Cancer 2013;132:2378–2387.
  • Sjöberg J, Halthur C, Kristinsson SY, et al. Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973–2009. Blood 2012;119:990–996.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.